VIDeOS for Smoking Cessation

Cancer Clinical Trial

Official title:

Video Interventions for Dependence On Smoking (VIDeOS) for Cancer Patients: A Randomized Controlled Pilot Study

Clinical Trial Details — Status: Not yet recruiting

Administrative data

• NCT number: NCT06307496
• Other study ID #: Pro00133913
• Status: Not yet recruiting
• Phase: N/A
• Start date: September 2024
• Est. completion date: July 2025

Study information

• Verified date: June 2024
• Source: Medical University of South Carolina
• Contact: Kinsey Pebley, PhD, MPH
• Phone: 843-779-5794
• Email: pebley[@]musc.edu
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

The purpose of the current study is to pilot the efficacy, feasibility, and acceptability of an evidence-based smoking cessation intervention adapted for cancer patients and delivered via video. Investigators aim to assess if this intervention is considered acceptable by participants, feasible to implement, and effective at increasing knowledge about smoking cessation before conducting a fully powered clinical trial.

Description:

A randomized controlled pilot study is being conducted to test the acceptability and feasibility of a smoking cessation intervention tailored for cancer patients that is delivered via video. Participants will be in a video intervention or control group that receives information about quitting smoking. Participants will complete surveys prior to randomization, and will complete additional surveys one week, one month, and three months post-randomization to provide their thoughts about the videos, information about changes to smoking behaviors, and knowledge about quitting smoking.

Recruitment information / eligibility

• Status: Not yet recruiting
• Enrollment: 40
• Est. completion date: July 2025
• Est. primary completion date: April 2025
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• Age 18 or older

• Diagnosed with cancer (any type)

• Receiving care at Medical University of South Carolina

• Reads and understands English language

• Currently smoking cigarettes (any amount)

Exclusion Criteria:

• Unstable or poorly managed medical or psychiatric conditions that impair cognition and ability to provide informed consent (e.g., dementia, active psychosis).

Related Conditions & MeSH terms

• Cancer
• Smoking Cessation

Intervention

Other:
• Smoking cessation intervention
Receive links to smoking cessation videos
• Informational intervention
Receive NCI's "Clearing the Air" booklet

Locations

Country	Name	City	State
n/a

Sponsors (2)

Lead Sponsor	Collaborator
Medical University of South Carolina	National Cancer Institute (NCI)

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Acceptability	Acceptability will be measured using the Acceptability of Intervention measure, which contains four items with answer options on a scale from 1-5, with higher scores indicating higher acceptability. We will consider the intervention "acceptable" if an average score of 4 or higher is obtained.	1 week post-randomization
Primary	Feasibility	Feasibility will be measured using the Feasibility of Intervention measure, which contains four items with answer options on a scale from 1-5, with higher scores indicating higher feasibility. We will consider the intervention "feasible" if an average score of 4 or higher is obtained.	1 week post-randomization
Primary	Retention Rates	We will determine if there are differences in retention rates between intervention groups.	1 week, 1 month, and 3 months post-randomization
Secondary	Changes in knowledge about quitting smoking	We will assess changes in knowledge about tools to quit smoking and the role of nicotine, etc. from prior to randomization (before the intervention is delivered) to post-randomization follow-ups. These questions will be generated by the study investigators based on video content.	Baseline, 1 week, 1 month, and 3 months post-randomization
Secondary	Changes in smoking behaviors	We will assess the number of 24-hour quit attempts and 7-day point prevalence at 1 week, 1 month, and 3 month follow-ups.	1 week, 1 month, and 3 months post-randomization